I do recall that study from this committee, and, of course, we paid close attention to it at the time. As you know, the CORE was appointed in 2019. Part of the early days of that office was setting up the procedures and so on. That may be part of the reason why perhaps there weren't many cases in the early days.
As I understand it, and it's public knowledge, the cases are always posted quarterly on the CORE's website. There are currently 21 active cases: five in the intake phase, six in an initial assessment, nine under investigation, and one where recommendations have been made to the company. I've spoken with the office of the CORE recently, and my understanding is that members of the group are very busy these days and are seeing some relatively good success with their efforts.